- Home
- CNTB vs UG Comparison
CNTB vs UG Comparison
Compare CNTB & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- UG
- Stock Information
- Founded
- CNTB 2012
- UG 1942
- Country
- CNTB United States
- UG United States
- Employees
- CNTB N/A
- UG N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- UG Package Goods/Cosmetics
- Sector
- CNTB Health Care
- UG Consumer Discretionary
- Exchange
- CNTB Nasdaq
- UG Nasdaq
- Market Cap
- CNTB 55.2M
- UG 50.1M
- IPO Year
- CNTB 2021
- UG N/A
- Fundamental
- Price
- CNTB $0.87
- UG $10.50
- Analyst Decision
- CNTB Strong Buy
- UG
- Analyst Count
- CNTB 1
- UG 0
- Target Price
- CNTB $8.00
- UG N/A
- AVG Volume (30 Days)
- CNTB 22.8K
- UG 8.5K
- Earning Date
- CNTB 04-15-2025
- UG 03-21-2025
- Dividend Yield
- CNTB N/A
- UG 6.63%
- EPS Growth
- CNTB N/A
- UG 38.11
- EPS
- CNTB N/A
- UG 0.76
- Revenue
- CNTB $24,116,000.00
- UG $12,312,275.00
- Revenue This Year
- CNTB N/A
- UG N/A
- Revenue Next Year
- CNTB $63.90
- UG N/A
- P/E Ratio
- CNTB N/A
- UG $14.25
- Revenue Growth
- CNTB N/A
- UG 11.51
- 52 Week Low
- CNTB $0.77
- UG $7.02
- 52 Week High
- CNTB $2.66
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- CNTB 37.85
- UG 44.74
- Support Level
- CNTB $0.91
- UG $10.31
- Resistance Level
- CNTB $0.95
- UG $11.08
- Average True Range (ATR)
- CNTB 0.08
- UG 0.38
- MACD
- CNTB -0.01
- UG -0.07
- Stochastic Oscillator
- CNTB 27.95
- UG 23.85
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.